Cecha
Failure of development of between one and six teeth
Nazwa kliniczna: Hypodontia
The absence of five or less teeth from the normal series by a failure to develop.
Podsumowanie
- Znana także jako
- Missing between one and six teeth
- Układ organizmu
- Abnormality of head or neck
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Failure of development of between one and six teeth, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test242 genów powiązanych z Failure of development of between one and six teeth
Zmiany w tych genach powodują rzadkie choroby, w których występuje Failure of development of between one and six teeth. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| AMOTL1angiomotin like 1 | Zawsze | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Zawsze | W 2 chorobach |
| EDAectodysplasin A | Zawsze | W 2 chorobach |
| EDARADDEDAR associated via death domain | Zawsze | W 5 chorobach |
| GRHL2grainyhead like transcription factor 2 | Zawsze | W 1 chorobie |
| IKBKGinhibitor of nuclear factor kappa B kinase regulatory subunit gamma | Zawsze | W 4 chorobach |
| IRX5iroquois homeobox 5 | Zawsze | W 1 chorobie |
| KDM6Blysine demethylase 6B | Zawsze | W 1 chorobie |
| LEMD2LEM domain nuclear envelope protein 2 | Zawsze | W 1 chorobie |
| NECTIN1nectin cell adhesion molecule 1 | Zawsze | W 4 chorobach |
| PPP2R3Cprotein phosphatase 2 regulatory subunit B''gamma | Zawsze | W 1 chorobie |
| PTBP1polypyrimidine tract binding protein 1 | Zawsze | W 1 chorobie |
| TP63tumor protein p63 | Zawsze | W 7 chorobach |
| TSPEARthrombospondin type laminin G domain and EAR repeats | Zawsze | W 1 chorobie |
| UBE3Cubiquitin protein ligase E3C | Zawsze | W 1 chorobie |
| WNT10AWnt family member 10A | Zawsze | W 3 chorobach |
| ACOX1acyl-CoA oxidase 1 | Bardzo często (80–99%) | W 1 chorobie |
| CPLX1complexin 1 | Bardzo często (80–99%) | W 2 chorobach |
| CTBP1C-terminal binding protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| CTNNB1catenin beta 1 | Bardzo często (80–99%) | W 1 chorobie |
| EDARectodysplasin A receptor | Bardzo często (80–99%) | W 3 chorobach |
| EVCEvC ciliary complex subunit 1 | Bardzo często (80–99%) | W 3 chorobach |
| EVC2EvC ciliary complex subunit 2 | Bardzo często (80–99%) | W 3 chorobach |
| FGFR3fibroblast growth factor receptor 3 | Bardzo często (80–99%) | W 2 chorobach |
| KDF1keratinocyte differentiation factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| KIF1Ckinesin family member 1C | Bardzo często (80–99%) | W 1 chorobie |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| LRP6LDL receptor related protein 6 | Bardzo często (80–99%) | W 1 chorobie |
| MSX1msh homeobox 1 | Bardzo często (80–99%) | W 4 chorobach |
| NELFAnegative elongation factor complex member A | Bardzo często (80–99%) | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Bardzo często (80–99%) | W 2 chorobach |
| NSD2nuclear receptor binding SET domain protein 2 | Bardzo często (80–99%) | W 2 chorobach |
| PIGGphosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) | Bardzo często (80–99%) | W 1 chorobie |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Bardzo często (80–99%) | W 1 chorobie |
| POLR1CRNA polymerase I and III subunit C | Bardzo często (80–99%) | W 1 chorobie |
| POLR3ARNA polymerase III subunit A | Bardzo często (80–99%) | W 5 chorobach |
| POLR3BRNA polymerase III subunit B | Bardzo często (80–99%) | W 2 chorobach |
| RPS6KA3ribosomal protein S6 kinase A3 | Bardzo często (80–99%) | W 2 chorobach |
| TRAF6TNF receptor associated factor 6 | Bardzo często (80–99%) | W 1 chorobie |
| ACDACD shelterin complex subunit and telomerase recruitment factor | Często (30–79%) | W 1 chorobie |
Pokaż jeszcze 202 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2 | Często (30–79%) | W 2 chorobach |
| ARL6ARF like GTPase 6 | Często (30–79%) | W 2 chorobach |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Często (30–79%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Często (30–79%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Często (30–79%) | W 2 chorobach |
| BBS10Bardet-Biedl syndrome 10 | Często (30–79%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Często (30–79%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Często (30–79%) | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Często (30–79%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Często (30–79%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Często (30–79%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Często (30–79%) | W 1 chorobie |
| CEP19centrosomal protein 19 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Często (30–79%) | W 2 chorobach |
| CHSY1chondroitin sulfate synthase 1 | Często (30–79%) | W 1 chorobie |
| CLDN1claudin 1 | Często (30–79%) | W 2 chorobach |
| CLIP2CAP-Gly domain containing linker protein 2 | Często (30–79%) | W 1 chorobie |
| CTC1CST telomere replication complex component 1 | Często (30–79%) | W 1 chorobie |
| DDX59DEAD-box helicase 59 | Często (30–79%) | W 2 chorobach |
| DKC1dyskerin pseudouridine synthase 1 | Często (30–79%) | W 1 chorobie |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Często (30–79%) | W 1 chorobie |
| DYNC2LI1dynein cytoplasmic 2 light intermediate chain 1 | Często (30–79%) | W 2 chorobach |
| EIF4Heukaryotic translation initiation factor 4H | Często (30–79%) | W 1 chorobie |
| ELNelastin | Często (30–79%) | W 2 chorobach |
| FGFR2fibroblast growth factor receptor 2 | Często (30–79%) | W 2 chorobach |
| FGFRL1fibroblast growth factor receptor like 1 | Często (30–79%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Często (30–79%) | W 1 chorobie |
| GDF5growth differentiation factor 5 | Często (30–79%) | W 1 chorobie |
| GLI1GLI family zinc finger 1 | Często (30–79%) | W 1 chorobie |
| GTF2Igeneral transcription factor IIi | Często (30–79%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Często (30–79%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Często (30–79%) | W 1 chorobie |
| HECTD4HECT domain E3 ubiquitin protein ligase 4 | Często (30–79%) | W 1 chorobie |
| IFT122intraflagellar transport 122 | Często (30–79%) | W 2 chorobach |
| IFT172intraflagellar transport 172 | Często (30–79%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Często (30–79%) | W 1 chorobie |
| IFT43intraflagellar transport 43 | Często (30–79%) | W 1 chorobie |
| IFT52intraflagellar transport 52 | Często (30–79%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Często (30–79%) | W 1 chorobie |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Często (30–79%) | W 1 chorobie |
| KDM6Alysine demethylase 6A | Często (30–79%) | W 2 chorobach |
| KMT2Alysine methyltransferase 2A | Często (30–79%) | W 1 chorobie |
| KMT2Dlysine methyltransferase 2D | Często (30–79%) | W 1 chorobie |
| LIMK1LIM domain kinase 1 | Często (30–79%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Często (30–79%) | W 1 chorobie |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Często (30–79%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Często (30–79%) | W 1 chorobie |
| MKKSMKKS centrosomal shuttling protein | Często (30–79%) | W 1 chorobie |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 1 chorobie |
| MLXIPLMLX interacting protein like | Często (30–79%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Często (30–79%) | W 1 chorobie |
| NHP2NHP2 ribonucleoprotein | Często (30–79%) | W 1 chorobie |
| NOP10NOP10 ribonucleoprotein | Często (30–79%) | W 1 chorobie |
| NPHP1nephrocystin 1 | Często (30–79%) | W 1 chorobie |
| NPM1nucleophosmin 1 | Często (30–79%) | W 1 chorobie |
| OFD1OFD1 centriole and centriolar satellite protein | Często (30–79%) | W 1 chorobie |
| OTUD5OTU deubiquitinase 5 | Często (30–79%) | W 1 chorobie |
| PARNpoly(A)-specific ribonuclease | Często (30–79%) | W 1 chorobie |
| PERPp53 apoptosis effector related to PMP22 | Często (30–79%) | W 1 chorobie |
| POLR3KRNA polymerase III subunit K | Często (30–79%) | W 1 chorobie |
| PORCNporcupine O-acyltransferase | Często (30–79%) | W 2 chorobach |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Często (30–79%) | W 2 chorobach |
| PUS7pseudouridine synthase 7 | Często (30–79%) | W 1 chorobie |
| RBM28RNA binding motif protein 28 | Często (30–79%) | W 2 chorobach |
| RFC2replication factor C subunit 2 | Często (30–79%) | W 1 chorobie |
| RTEL1regulator of telomere elongation helicase 1 | Często (30–79%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Często (30–79%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Często (30–79%) | W 1 chorobie |
| SCNM1sodium channel modifier 1 | Często (30–79%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Często (30–79%) | W 1 chorobie |
| STX1Asyntaxin 1A | Często (30–79%) | W 1 chorobie |
| TBL2transducin beta like 2 | Często (30–79%) | W 1 chorobie |
| TERCtelomerase RNA component | Często (30–79%) | W 1 chorobie |
| TERTtelomerase reverse transcriptase | Często (30–79%) | W 1 chorobie |
| TINF2TERF1 interacting nuclear factor 2 | Często (30–79%) | W 1 chorobie |
| TMEM270transmembrane protein 270 | Często (30–79%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Często (30–79%) | W 1 chorobie |
| TRPV3transient receptor potential cation channel subfamily V member 3 | Często (30–79%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Często (30–79%) | W 1 chorobie |
| TYMSthymidylate synthetase | Często (30–79%) | W 1 chorobie |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Często (30–79%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Często (30–79%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Często (30–79%) | W 1 chorobie |
| WDR19WD repeat domain 19 | Często (30–79%) | W 1 chorobie |
| WDR35WD repeat domain 35 | Często (30–79%) | W 1 chorobie |
| WRAP53WD repeat containing antisense to TP53 | Często (30–79%) | W 1 chorobie |
| AARS1alanyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| ACTL6Bactin like 6B | Czasami (5–29%) | W 1 chorobie |
| ADAMTSL2ADAMTS like 2 | Czasami (5–29%) | W 1 chorobie |
| AP3B2adaptor related protein complex 3 subunit beta 2 | Czasami (5–29%) | W 1 chorobie |
| APCAPC regulator of Wnt signaling pathway | Czasami (5–29%) | W 1 chorobie |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Czasami (5–29%) | W 1 chorobie |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Czasami (5–29%) | W 1 chorobie |
| ATP6V1AATPase H+ transporting V1 subunit A | Czasami (5–29%) | W 1 chorobie |
| ATP6V1B2ATPase H+ transporting V1 subunit B2 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Czasami (5–29%) | W 1 chorobie |
| CACNA1Bcalcium voltage-gated channel subunit alpha1 B | Czasami (5–29%) | W 1 chorobie |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Czasami (5–29%) | W 1 chorobie |
| CDK19cyclin dependent kinase 19 | Czasami (5–29%) | W 1 chorobie |
| CELF2CUGBP Elav-like family member 2 | Czasami (5–29%) | W 1 chorobie |
| CEP152centrosomal protein 152 | Czasami (5–29%) | W 1 chorobie |
| CEP85Lcentrosomal protein 85L | Czasami (5–29%) | W 1 chorobie |
| CKAP2Lcytoskeleton associated protein 2L | Czasami (5–29%) | W 1 chorobie |
| CLTCclathrin heavy chain | Czasami (5–29%) | W 1 chorobie |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Czasami (5–29%) | W 1 chorobie |
| CREBBPCREB binding lysine acetyltransferase | Czasami (5–29%) | W 2 chorobach |
| CTSKcathepsin K | Czasami (5–29%) | W 2 chorobach |
| CYFIP2cytoplasmic FMR1 interacting protein 2 | Czasami (5–29%) | W 1 chorobie |
| DALRD3DALR anticodon binding domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Czasami (5–29%) | W 1 chorobie |
| DHDDSdehydrodolichyl diphosphate synthase subunit | Czasami (5–29%) | W 1 chorobie |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Czasami (5–29%) | W 1 chorobie |
| DNM1dynamin 1 | Czasami (5–29%) | W 1 chorobie |
| DVL1dishevelled segment polarity protein 1 | Czasami (5–29%) | W 1 chorobie |
| DVL3dishevelled segment polarity protein 3 | Czasami (5–29%) | W 1 chorobie |
| EEF1A2eukaryotic translation elongation factor 1 alpha 2 | Czasami (5–29%) | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Czasami (5–29%) | W 1 chorobie |
| FBXO28F-box protein 28 | Czasami (5–29%) | W 1 chorobie |
| FGF10fibroblast growth factor 10 | Czasami (5–29%) | W 1 chorobie |
| FGF12fibroblast growth factor 12 | Czasami (5–29%) | W 1 chorobie |
| FGF3fibroblast growth factor 3 | Czasami (5–29%) | W 1 chorobie |
| FOSL2FOS like 2, AP-1 transcription factor subunit | Czasami (5–29%) | W 1 chorobie |
| FOXC1forkhead box C1 | Czasami (5–29%) | W 2 chorobach |
| FOXG1forkhead box G1 | Czasami (5–29%) | W 1 chorobie |
| FZD2frizzled class receptor 2 | Czasami (5–29%) | W 1 chorobie |
| FZR1fizzy and cell division cycle 20 related 1 | Czasami (5–29%) | W 1 chorobie |
| GABBR2gamma-aminobutyric acid type B receptor subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GABRA2gamma-aminobutyric acid type A receptor subunit alpha2 | Czasami (5–29%) | W 1 chorobie |
| GABRA5gamma-aminobutyric acid type A receptor subunit alpha5 | Czasami (5–29%) | W 1 chorobie |
| GABRB2gamma-aminobutyric acid type A receptor subunit beta2 | Czasami (5–29%) | W 1 chorobie |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Czasami (5–29%) | W 1 chorobie |
| GRHL3grainyhead like transcription factor 3 | Czasami (5–29%) | W 2 chorobach |
| GRIN2Dglutamate ionotropic receptor NMDA type subunit 2D | Czasami (5–29%) | W 1 chorobie |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Czasami (5–29%) | W 1 chorobie |
| HMGA2high mobility group AT-hook 2 | Czasami (5–29%) | W 1 chorobie |
| IRF6interferon regulatory factor 6 | Czasami (5–29%) | W 4 chorobach |
| KCNA2potassium voltage-gated channel subfamily A member 2 | Czasami (5–29%) | W 1 chorobie |
| KCNB1potassium voltage-gated channel subfamily B member 1 | Czasami (5–29%) | W 1 chorobie |
| KCNC2potassium voltage-gated channel subfamily C member 2 | Czasami (5–29%) | W 1 chorobie |
| KCNH1potassium voltage-gated channel subfamily H member 1 | Czasami (5–29%) | W 1 chorobie |
| KCNH5potassium voltage-gated channel subfamily H member 5 | Czasami (5–29%) | W 1 chorobie |
| KCNN3potassium calcium-activated channel subfamily N member 3 | Czasami (5–29%) | W 1 chorobie |
| LEMD3LEM domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| LMNAlamin A/C | Czasami (5–29%) | W 1 chorobie |
| LRP4LDL receptor related protein 4 | Czasami (5–29%) | W 2 chorobach |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Czasami (5–29%) | W 1 chorobie |
| MTX2metaxin 2 | Czasami (5–29%) | W 1 chorobie |
| NECAP1NECAP endocytosis associated 1 | Czasami (5–29%) | W 1 chorobie |
| NKX6-2NK6 homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| NTRK2neurotrophic receptor tyrosine kinase 2 | Czasami (5–29%) | W 1 chorobie |
| NUS1NUS1 dehydrodolichyl diphosphate synthase subunit | Czasami (5–29%) | W 1 chorobie |
| NXNnucleoredoxin | Czasami (5–29%) | W 1 chorobie |
| PACS2phosphofurin acidic cluster sorting protein 2 | Czasami (5–29%) | W 1 chorobie |
| PARS2prolyl-tRNA synthetase 2, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| PITX2paired like homeodomain 2 | Czasami (5–29%) | W 2 chorobach |
| POLR1ARNA polymerase I subunit A | Czasami (5–29%) | W 1 chorobie |
| POP1POP1 ribonuclease P/MRP subunit | Czasami (5–29%) | W 1 chorobie |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Czasami (5–29%) | W 1 chorobie |
| RNF13ring finger protein 13 | Czasami (5–29%) | W 1 chorobie |
| ROR2ROR family WNT receptor 2 | Czasami (5–29%) | W 1 chorobie |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Czasami (5–29%) | W 1 chorobie |
| SCN3Asodium voltage-gated channel alpha subunit 3 | Czasami (5–29%) | W 1 chorobie |
| SCN8Asodium voltage-gated channel alpha subunit 8 | Czasami (5–29%) | W 1 chorobie |
| SCUBE3signal peptide, CUB domain and EGF like domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| SLC13A5solute carrier family 13 member 5 | Czasami (5–29%) | W 2 chorobach |
| SLC1A2solute carrier family 1 member 2 | Czasami (5–29%) | W 1 chorobie |
| SLC38A3solute carrier family 38 member 3 | Czasami (5–29%) | W 1 chorobie |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Czasami (5–29%) | W 1 chorobie |
| SMG8SMG8 nonsense mediated mRNA decay factor | Czasami (5–29%) | W 1 chorobie |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Czasami (5–29%) | W 1 chorobie |
| SYNJ1synaptojanin 1 | Czasami (5–29%) | W 1 chorobie |
| SZT2SZT2 subunit of KICSTOR complex | Czasami (5–29%) | W 1 chorobie |
| TBX3T-box transcription factor 3 | Czasami (5–29%) | W 2 chorobach |
| TRAK1trafficking kinesin protein 1 | Czasami (5–29%) | W 1 chorobie |
| TWIST2twist family bHLH transcription factor 2 | Czasami (5–29%) | W 1 chorobie |
| UBA5ubiquitin like modifier activating enzyme 5 | Czasami (5–29%) | W 1 chorobie |
| UFSP2UFM1 specific peptidase 2 | Czasami (5–29%) | W 1 chorobie |
| WNT5AWnt family member 5A | Czasami (5–29%) | W 1 chorobie |
| YWHAGtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | Czasami (5–29%) | W 1 chorobie |
| ZMPSTE24zinc metallopeptidase STE24 | Czasami (5–29%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Rzadko (1–4%) | W 1 chorobie |
| MID1midline 1 | Rzadko (1–4%) | W 1 chorobie |
| NKX2-1NK2 homeobox 1 | Rzadko (1–4%) | W 1 chorobie |
| TAF11TATA-box binding protein associated factor 11 | Rzadko (1–4%) | W 1 chorobie |
| BCL11BBCL11 transcription factor B | Nie odnotowano | W 1 chorobie |
| CCDC28Bcoiled-coil domain containing 28B | Nie odnotowano | W 1 chorobie |
| CDH1cadherin 1 | Nie odnotowano | W 1 chorobie |
| COL17A1collagen type XVII alpha 1 chain | Nie odnotowano | W 1 chorobie |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Nie odnotowano | W 1 chorobie |
| FLNBfilamin B | Nie odnotowano | W 1 chorobie |
| HSPA9heat shock protein family A (Hsp70) member 9 | Nie odnotowano | W 1 chorobie |
| LAMB3laminin subunit beta 3 | Nie odnotowano | W 1 chorobie |
| NFKBIANFKB inhibitor alpha | Nie odnotowano | W 1 chorobie |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Nie odnotowano | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Nie odnotowano | W 1 chorobie |
| PTH1Rparathyroid hormone 1 receptor | Nie odnotowano | W 1 chorobie |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Nie odnotowano | W 1 chorobie |
| SLC39A13solute carrier family 39 member 13 | Nie odnotowano | W 1 chorobie |
| TRIM37tripartite motif containing 37 | Nie odnotowano | W 1 chorobie |
| XYLT1xylosyltransferase 1 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni